ALTERATION IN SERUM LIPID PROFILE LEVELS IN IRAQI WOMEN WITH BREAST CANCER BEFORE AND AFTER CHEMOTHERAPY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i5.24423Keywords:
Breast cancer, Lipid profile, Triglyceride, High-density lipoprotein, Chemotherapy, Iraqi womenAbstract
Objective: Investigating the role of alterations in lipid profile in Iraqi women with breast cancer before and after chemotherapy.
Methods: A total number of 100 patients aged 25–47 years were enrolled in this study, including 35 breast cancer treatment patients, 30 treatment patients, and 10 and 25 healthy women benefactor. All samples were collected from August 2016 to February 2017 from Oncology Hospital/Medical city in Baghdad; however, control group samples were collected from outside the hospital. Serum total cholesterol, serum triglyceride, and serum high-density lipoprotein cholesterol (HDL-C) were measured by spectrophotometer using a kit provided by Linear Chemicals.
Results: The results show a highly significant increment (p˂0.01) in lipid profile in breast cancer, especially in diagnosis group as compared with other groups.
Conclusion: The alteration in cholesterol, triglyceride, HDL-C, and very low-density lipoprotein is highly connected with breast cancer in Iraqi women, progression of disease and treatment effect.
Downloads
References
Siegel RL, Miller KD, Jemal A. Cancer statistics 2015. CA Cancer J Clin 2015;65:5-29.
Jagsi R. Progress and controversies: Radiation therapy for invasive breast cancer. CA Cancer J Clin 2014;64:135-52.
Paley PJ. Screening for the major malignancies affecting women: Current guidelines. Am J Obstet Gynecol 2001;184:1021-30.
Ritu Y, Rajeev S, Preeti C. ER, PR, Her2/Neustatus and Relation to clinic pathological factors in breast carcinoma. Int J Pharm Pharm Sci 2015;8:287-90.
Cicatiello L, Mutarelli M, Grober OM, Paris O, Ferraro L, Ravo M, et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 2010;176:2113-30.
Kumar K, Sachdanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochem Int 1991;23:581-9.
Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL, et al. Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int 1999;47:681-90.
Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2002;94:1773-9.
Lalloo F, Varley J, Ellis D, Moran A, O’Dair L, Pharoah P, et al. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 2003;361:1101-2.
Adam A, Elgadir AM, Salama M. Anti-breast cancer from various natural sources, review. Int J Pharm Pharm Sci 2015;7:44-7.
Samson B, Jayabharathi B. Lived in experience of women with breast cancer. Asian J Pharm Clin Res 2016;9:80-4.
Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE, Kulkarni SA, et al. Multiple primary tumors in men with breast cancer diagnoses: A SEER database review. J Surg Oncol 2009;99:16-9.
Lane DM, Boatman KK, McCarty WJ. Serum lipid and lipoproteins in women with breast masses breast cancer. Res Treat 1995;34:161-9.
Knapp ML, AL Sheibani S, Richer P. Galteration of serum lipids in breast cancer. Effect of disease activity treatment and hormonal factor. Clin Chem 1991;37:2093-101.
Ahiuwalia S, Shah N. Animal venom for treating breast cancer. Int J Pharm Pharm Sci 2014;6:24-30.
Wynder EL, Cohen LA, Muscat JE, Winters B, Dwyer JT, Blackburn G, et al. Breast cancer: Weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997;89:766-75.
Ray G, Husain SA. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 2001;34:71-6.
Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjørge T, Borena W, et al. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PloS One 2013;8:e54242.
Hussain DA, Ahmed S, Hoque M, Rabbi SM, Masood S, Shafi T, et al. Biochemical factors associated with breast cancer in Bangladeshi Women. Bangladesh J Med Biochem 2013;6:58-62.
Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: The women’s health initiative (United states). Cancer Causes Control2002;13:741-51.
King MC, Wieand S, Hale K, Lee M. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2. JAMA 2002;12:58-62.
Shyamala G, Schneider W, Guiot MC. Estrogen dependent regulation of estrogen-receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity. Br Med J 1992;2:121-8.
Ridker PM, Stampfer MJ, Hennekens CH. Plasma concentration of lipoprotein and the risk factors of breast cancer JAMA 1995;5:31-5.
Liqaa OA. Study effect of breast cancer on some hematological and biochemical parameters in babylon province, Iraq. J Pharm Bioallied Sci 2014;9:20-4.
Owiredu WK, Donkor S, Addai BW, Amidu N. Serum lipid profile of breast cancer patients. Pak J Biol Sci 2009;12:332-8.
Abdullah EA, Ahmed FA, Adam ZE, Ibrahim OB, Morsi AN. The association between lipid profile and breast cancer in Sudanese women. Sch J Appl Med Sci 2015;3:1992-2000.
Sung J, Ha M, Song YM. Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 2009;20:1055-60.
Chang SJ, Hou MF, Tsai SM, Wu SH, Ann Hou L, Ma H, et al. The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med 2007;45:1219-23.
Peela JR, Jarari AM, El Saiety SO, El BusaifiS, El Awamy H. The relationship between serum Lipids and Breast cancer in Libya. Clin Chem 2010;56 (Supl-6)..
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
